Changes in serum interleukin-6 levels as possible predictor of efficacy of tocilizumab treatment in rheumatoid arthritis

导出原文传递

翻译打印收藏纠错

作者： Aizu, Motohiko ^[1] ; Mizushima, Ichiro ^[2] ; Nakazaki, Satoshi ^[3] ; Nakashima, Akikatsu ^[4] ; Kato, Takashi ^[5] ; Murayama, Takashi ^[6] ; Kato, Shinichi ^[7] ; Katsuki, Yasuo ^[8] ; Ogane, Kunihiro ; Fujii, Hiroshi ; Yamada, Kazunori ; Nomura, Hideki ; Yachie, Akihiro ; Yamagishi, Masakazu ; Kawano, Mitsuhiro

作者单位： Kanazawa Univ Hosp, Div Rheumatol, Dept Internal Med, Kanazawa, Ishikawa, Japan ^[1] Ishikawa Prefectural Cent Hosp, Kanazawa, Ishikawa, Japan ^[2] Kanazawa Univ Hosp, Dept Gen Internal Med, Kanazawa, Ishikawa, Japan ^[3] Kanazawa Univ, Dept Pediat, Grad Sch Med, Kanazawa, Ishikawa, Japan ^[4] Kanazawa Jouhoku Hosp, Kanazawa, Ishikawa, Japan ^[5] Kanazawa Univ, Div Cardiol, Dept Cardiovasc & Internal Med, Grad Sch Med, Kanazawa, Ishikawa, Japan ^[6] Yawata Med Ctr, Komatsu, Japan ^[7] Kanazawa Univ, Div Rheumatol, Dept Cardiovasc & Internal Med, Grad Sch Med, Kanazawa, Ishikawa ^[8]

关键词 Interleukin-6 tocilizumab rheumatoid arthritis disease activity score 28 clinical disease activity index

发布时间 2019-02-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交